Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 275

Related Citations for PubMed (Select 10029077)

4.

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage.

Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA, Lynch HT.

Cancer. 1996 Feb 15;77(4):697-709.

PMID:
8616762
5.

BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families.

Sarantaus L, Auranen A, Nevanlinna H.

Int J Oncol. 2001 Apr;18(4):831-5.

PMID:
11251181
6.

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.

Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA.

Am J Hum Genet. 2000 Apr;66(4):1259-72. Epub 2000 Mar 16.

7.

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.

Clin Cancer Res. 2002 Dec;8(12):3776-81.

8.

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

Verhoog LC, Brekelmans CT, Seynaeve C, Dahmen G, van Geel AN, Bartels CC, Tilanus-Linthorst MM, Wagner A, Devilee P, Halley DJ, van den Ouweland AM, Meijers-Heijboer EJ, Klijn JG.

J Clin Oncol. 1999 Nov;17(11):3396-402.

PMID:
10550133
9.

Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland.

Eerola H, Vahteristo P, Sarantaus L, Kyyrönen P, Pyrhönen S, Blomqvist C, Pukkala E, Nevanlinna H, Sankila R.

Int J Cancer. 2001 Aug 1;93(3):368-72.

PMID:
11433401
10.

BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing.

Rubin SC, Blackwood MA, Bandera C, Behbakht K, Benjamin I, Rebbeck TR, Boyd J.

Am J Obstet Gynecol. 1998 Apr;178(4):670-7.

PMID:
9579428
12.

BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy.

Santarosa M, Dolcetti R, Magri MD, Crivellari D, Tibiletti MG, Gallo A, Tumolo S, Della Puppa L, Furlan D, Boiocchi M, Viel A.

Int J Cancer. 1999 Sep 24;83(1):5-9.

PMID:
10449599
13.

A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer.

Lu KH, Cramer DW, Muto MG, Li EY, Niloff J, Mok SC.

Obstet Gynecol. 1999 Jan;93(1):34-7.

PMID:
9916952
14.

Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.

Gaffney DK, Hemmersmeier J, Holden J, Marshall J, Smith LM, Avizonis V, Tran T, Neuhausen SL.

Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):539-46.

PMID:
11173152
15.

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.

Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E.

Int J Cancer. 2000 Jun 1;86(5):737-40.

PMID:
10797299
16.

Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.

Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P.

Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. Review.

PMID:
10985881
17.

Differences between hereditary and sporadic ovarian cancer.

Zweemer RP, Verheijen RH, Menko FH, Gille JJ, van Diest PJ, Coebergh JW, Shaw PA, Jacobs IJ, Kenemans P.

Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):151-3.

PMID:
10206407
18.

Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations.

Pierce LJ, Strawderman M, Narod SA, Oliviotto I, Eisen A, Dawson L, Gaffney D, Solin LJ, Nixon A, Garber J, Berg C, Isaacs C, Heimann R, Olopade OI, Haffty B, Weber BL.

J Clin Oncol. 2000 Oct 1;18(19):3360-9.

PMID:
11013276
19.

Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.

Zweemer RP, Shaw PA, Verheijen RM, Ryan A, Berchuck A, Ponder BA, Risch H, McLaughlin JR, Narod SA, Menko FH, Kenemans P, Jacobs IJ.

J Clin Pathol. 1999 May;52(5):372-5.

20.

Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families.

Vaziri SA, Krumroy LM, Rostai M, Casey G.

Hum Mutat. 2001;17(1):74.

PMID:
11139249
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk